Skip to content

A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.

An intervention based Prospective study to assess the efficacy of CognitiveBotics software (an indigenously developed AI based software) in providing the integrated interventions in different domains - the social or emotional, language or communication, cognitive and movement or physical development of children diagnosed with Autism Spectrum Disorder. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054257
Enrollment
20
Registered
2023-06-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: CognitiveBotics software: An indigenously developed AI based software which provides integrated interventions in different domains. The core concept of the product is based on the fact

Sponsors

CognitiveBotics Technologies Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children diagnosed ASD using assessment scales such as Childhood Autism Rating Scales (CARS) 2. Children with 2 to 18 years 3. Children with associated comorbidities will be included as long as the child is able to use the tool. 4. Ability to understand and respond to instructions given in English 5. Access to a device on which the software can be accessed using internet connection. 6. Parents who have consented for their child to use the software.

Exclusion criteria

Exclusion criteria: 1. Children with intellectual disability with IQ score 2. Parents who are not willing to consent to the study.

Design outcomes

Primary

MeasureTime frame
1. Ability to use the software & follow online instructions by the child & parents 2. Ability to log childâ??s day to day progress automatically and provide visual graphical feedback on the dashboard 3. Ability to measure the efficacy of the software, a. The childâ??s performance captured by the software at baseline T1 and at T2 b. We are comparing to proxy gold standard Clinical scales given below for progress at T1 and T2 i. Childhood Autism Rating Scale (CARS), ii. ATEC Autism Treatment Evaluation Checklist iii. VB MAPP c. Parent ILP checklist â?? at baseline T1 and end of the study T2Timepoint: Throughout the study

Secondary

MeasureTime frame
â?¢ To examine if the increase in the number of hours spent on the tool is corelated to the changes in the scores of the scales at T1 & T2.Timepoint: Throughout the study

Countries

India

Contacts

Public ContactT Bindu Rani

CognitiveBotics Technologies Private Limited

dr.harini.atturu@cognitivebotics.net9121009559

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026